Proclara is pioneering a new approach to treating neurodegenerative diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer’s, Parkinson’s, and other diseases caused by protei
Member count: 11-50
Total raised: $47M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Merieux De... | merieux-pa... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 07.09.2016 | Series E | $47M | - | citybizlis... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 09.09.2016 | Proclara B... | Proclara Biosciences, a Cambri... | USA | - | finsmes.co... |
| 07.09.2016 | Proclara g... | NeuroPhage Pharmaceuticals hop... | Biotech | - | fiercebiot... |
| 07.09.2016 | Proclara B... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 07.09.2016 | Proclara B... | CAMBRIDGE, MA, Biotechnology... | - | - | vcnewsdail... |